Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered having two or more ring hetero atoms of which at least one is nitrogen (e.g., selenazines, etc.) > The six-membered hetero ring consists of two nitrogens and four carbons (e.g., 1,2-diazines, etc.) > 1,3-diazines > Polycyclo ring system having the diazine ring as one of the cyclos > Bicyclo ring system having the diazine ring as one of the cyclos > The other cyclo in the bicyclo ring system is a benzene ring (e.g., quinazoline, etc.) > Additional nitrogen containing unsaturated hetero ring (e.g., thiazole, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Chemistry

Class Information
Number: 544/284
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered having two or more ring hetero atoms of which at least one is nitrogen (e.g., selenazines, etc.) > The six-membered hetero ring consists of two nitrogens and four carbons (e.g., 1,2-diazines, etc.) > 1,3-diazines > Polycyclo ring system having the diazine ring as one of the cyclos > Bicyclo ring system having the diazine ring as one of the cyclos > The other cyclo in the bicyclo ring system is a benzene ring (e.g., quinazoline, etc.) > Additional nitrogen containing unsaturated hetero ring (e.g., thiazole, etc.)
Description: Compounds having, in addition to the bicyclo ring system, a hetero ring which has at least one double bond between ring members and at least one ring nitrogen.

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Patent Number	Title Of Patent	Date Issued
8124604	Inhibitors of bruton's tyrosine kinase	Feb. 28, 2012
8114867	Oxazolidinone antibiotic derivatives	Feb. 14, 2012
8114893	Compounds and methods of use	Feb. 14, 2012
8101624	Quinazoline derivatives	Jan. 24, 2012
RE43098	Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof	Jan. 10, 2012
8088766	Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors	Jan. 3, 2012
8084620	Carbazole carboxamide compounds useful as kinase inhibitors	Dec. 27, 2011
8080558	4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent	Dec. 20, 2011
8075683	Isometric isoindoline yellow pigment	Dec. 13, 2011
8076160	Drug monitoring assay	Dec. 13, 2011
8071595	1,2-disubstituted heterocyclic compounds	Dec. 6, 2011
8071768	Alkylquinoline and alkylquinazoline kinase modulators	Dec. 6, 2011
8063210	Process and intermediate	Nov. 22, 2011
8058431	Fluorescent double stranded DNA binding dyes	Nov. 15, 2011
8053441	Pyrazolylquinazolinones as potassium channel openers	Nov. 8, 2011
8030495	Cyclopropyl pyrrolidine orexin receptor antagonists	Oct. 4, 2011
8026360	Substituted pyridazines as stearoyl-CoA desaturase inhibitors	Sep. 27, 2011
8008311	Methods and compostions utilizing quinazolinones	Aug. 30, 2011
7994181	6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents	Aug. 9, 2011
7989461	Substituted quinazolinamine compounds for the treatment of cancer	Aug. 2, 2011
7989460	Quinazoline derivatives as angiogenesis inhibitors	Aug. 2, 2011
7989462	4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof	Aug. 2, 2011
7977480	Synthesis of paliperidone	Jul. 12, 2011
7972600	IGF-IR antagonists as adjuvants for treatment of prostate cancer	Jul. 5, 2011
7968545	Compositions useful as inhibitors of voltage-gated ion channels	Jun. 28, 2011
7960387	2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses	Jun. 14, 2011
7951955	Antiviral agents	May. 31, 2011
7939539	Quinazolinone compounds as anticancer agents	May. 10, 2011
RE42353	Quinazoline derivatives and pharmaceutical compositions containing them	May. 10, 2011
7893071	Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic	Feb. 22, 2011
7879867	Crystalline antifungal compounds	Feb. 1, 2011
7879856	Diaminothiazoles useful as Axl inhibitors	Feb. 1, 2011
7875644	1-acyldihydropyrazole derivatives	Jan. 25, 2011
7872125	Phenylalanine derivatives	Jan. 18, 2011
7863282	Compositions useful as inhibitors of protein kinases	Jan. 4, 2011
7863270	IL-12 modulatory compounds	Jan. 4, 2011
7855194	Pyrimidine, quinazoline, pteridine and triazine derivatives	Dec. 21, 2010
7846925	Azolidinone-vinyl fused-benzene derivatives	Dec. 7, 2010
7820682	LPA receptor antagonist	Oct. 26, 2010
7786123	Indolylmaleimide derivatives	Aug. 31, 2010
7786043	2-(pyridin-2-yl)-pyrimidines and their use for controlling harmful fungi	Aug. 31, 2010
7772243	4-phenylamino-quinazolin-6-yl-amides	Aug. 10, 2010
7763627	Tie-2 modulators and methods of use	Jul. 27, 2010
7723330	Heterobicyclic pyrazole compounds and methods of use	May. 25, 2010
7718663	Quinazoline derivatives and medicaments	May. 18, 2010
7713983	Quinazolines useful as modulators of ion channels	May. 11, 2010
7713963	Acylated indanyl amines and their use as pharmaceuticals	May. 11, 2010
7700552	Macrocyclic inhibitors of hepatitis C virus	Apr. 20, 2010
7700607	Substituted pyridone compounds and methods of use	Apr. 20, 2010
7696216	Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives	Apr. 13, 2010